357 Results (Page 6 of 15)
Malaysia Markets Research Reports
Malaysia Lipid Lowering Drugs Market Analysis
Malaysia lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.
Malaysia Liver Cancer Drugs Market Analysis
Malaysia liver cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising incidence of liver cancer and the accessibility of novel medications are the two main drivers of market expansion over the forecast period. In the upcoming years, market expansion is anticipated to be fueled by increased investments in the research & development industry and the discovery of novel medicines. The major key players in this market are Bayer HealthCare Pharmaceuticals Inc. (Germany), Bristol-Myers & Squibb Company (US), Pfizer Inc. (US), Exelixis, Inc. (US), Merck Sharp & Dohme Corp. (US), Eisai Inc. (Japan), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland).
Malaysia Mammography Device Market Analysis
Malaysia mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.
Malaysia Medical Cannabis Drugs Market Analysis
Malaysia medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.
Malaysia Medical Electronics Market Analysis
Malaysia medical electronics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence and prevalence of chronic diseases, the growing elderly population, and the expanding use of machine vision are the few factors that will affect medical electronic market. The increased incidence of chronic diseases like cancer, neurological diseases, cardiovascular diseases, respiratory diseases, and others is the main factor driving market expansion. Some of the major key players in this market are Analog Devices, Inc., Texas Instruments Incorporated., Medtronic, STMicroelectronics, Mouser Electronics, Inc., etc.
Malaysia Medical Imaging Market Analysis
Malaysia medical imaging market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Teaching hospitals and universities are projected to need more modern imaging modalities in order to train students in cutting-edge technology, which is anticipated to have a significant impact on market growth. The major key players in this market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corp., Mindray Medical International, Esaote, Hologic, Inc., Samsung Medison Co., Ltd., Koning Corporation, PerkinElmer Inc., FUJIFILM VisualSonics Inc., Cubresa Inc.
Malaysia Medical Information Market Analysis
Malaysia medical information market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to grow due to the increase in demand for the creation of new drugs, the creation of technologically advanced healthcare solutions, and the ease with which information about healthcare products can be accessed. The major key players in this market are Accenture Plc, Change Healthcare Inc., Cognizant Technology Solutions Corp., Ergomed Plc, HCL Technologies Ltd., Infosys Ltd., IQVIA Holdings Inc., MakroCare, Parexel International Corp., ProPharma Group Holdings LLC.
Malaysia Medical X-ray Market Analysis
Malaysia medical X-ray market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. One of the key factors driving the expansion of the medical X-ray market is the rising incidence of bone fractures. Other indirect market growth factors include increased personal disposable income, increasing rates of traffic accidents, and rising costs for R&D operations. Some of the major key players in this market are General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., Carestream Health., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., etc.
Malaysia Melanoma Drugs Market Analysis
Malaysia melanoma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. This market is growing as a result of factors like an increase in melanoma incidence, greater awareness of available melanoma diagnostic and treatment options, and technological advancements in melanoma drugs. The major key players in this market are Novartis, Roche Holding AG, GlaxoSmithKline, Pfizer, Merck Group, Bristol Myers Squibb (BMY), Amgen, Genentech, Eisai Co. Ltd, Janssen Biotech, BeiGene Ltd, Iovance Biotherapeutics Inc., AB Science, Grand Pharmaceutical Group Co., Ltd. and, Navidea Biopharmaceuticals.
Malaysia Meningococcal Vaccines Market Analysis
Malaysia meningococcal vaccines market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Malaysia Metabolic Disorder Drugs Market Analysis
Malaysia metabolic disorder drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The ageing population, rising diabetes and obesity rates, and the prevalence of metabolic disorders are all driving factors for the global market for medications treating these conditions. Another element fueling the expansion of this market is an increase in public awareness of various ailments and associated pharmacological treatments. Some of the major key players in this market are AbbVie, Actelion Pharmaceuticals, Amgen, Astra Zeneca, Biocon, BioMarin Pharmaceutical, etc.
Malaysia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis
Malaysia Methicillin-resistant Staphylococcus Aureus (MRSA) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in governmental and private financing for research and development of novel anti-MRSA medications as well as their improved screening are the main drivers of the growth of the market for treating methicillin-resistant staphylococcus aureus (MRSA). Some of the major key players in this market are Merck & Co., Inc., Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Melinta Therapeutics, Inc., etc.
Malaysia Microspheres Market Analysis
Malaysia microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.
Malaysia Migraine Drugs Market Analysis
Malaysia migraine drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. High alcohol consumption, rising healthcare costs, rising job stress, and rising medicine demand are all expected to drive market expansion. In the years ahead, it is anticipated that there will be a rise in public knowledge of migraines and available treatments which will further act as a driver for Migraine Drugs Market. The major key players in this market are Amgen, Abbott Laboratories, Allergan, Eli Lilly, Pfizer, Inc., AstraZeneca, Johnson and Johnson Services, Inc., and GlaxoSmithKline.
Malaysia Multiple Myeloma Drugs Market Analysis
Malaysia multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.
Malaysia Nanomedicine Market Analysis
Malaysia nanomedicine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Shortly, significant advancements and the recent commercialization of goods like mRNA- and liposome-based vaccines are anticipated to fuel the rise of nanomedicines. The major key players in this market are Abbott Laboratories, CombiMatrix Corporation, Celgene Corporation, etc.
Malaysia Nanotechnology Drugs Delivery Market Analysis
Malaysia nanotechnology drugs delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for nanotechnology medication delivery is heavily influenced by factors like expanding public awareness of nanotechnology, an increase in the prevalence of chronic illnesses, technological improvement, and rising government investment in nanotechnology in various emerging nations. The major key players in this market are AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., and Novartis International AG.
Malaysia NSCLC Drugs Market Analysis
Malaysia NSCLC Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. During the projection period, the global non-small cell lung cancer market will grow due to the rise in cancer cases worldwide. Oral medications are predicted to accelerate market expansion. Given that the majority of medications are accessible in capsule and tablet form and that this is a very practical mode of administration, the category is anticipated to accelerate the global market.The global NSCLC Drugs market’s major key players are AstraZeneca PLC, Roche Holding AG, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, Novartis AG, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Johnson & Johnson.
Malaysia Oncology Biosimilars Market Analysis
Malaysia oncology biosimilars market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased incidence of cancer is driving the global market. Furthermore, the market is expanding as more people become aware of the existence of oncology biosimilars. Additionally, the advancements in biosimilar manufacturing technologies and procedures have expanded production capacities. The major key players in this market are Sandoz International GmbH, Celltrion Inc., Pfizer Inc., Amgen Inc., Samsung Bioepis, etc.
Malaysia Oncology/Cancer Drugs Market Analysis
Malaysia oncology/cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally rising cancer rates, rising demand for cutting-edge treatments like targeted medication therapies, an increase in the geriatric population, and pervasive lifestyle behaviors like smoking, drinking, and not exercising will all have a positive impact on the market during the projected period. The major key players in this market are Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, etc.
Malaysia Ophthalmic Drugs Market Analysis
Malaysia ophthalmic drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factors driving the growth of the global ophthalmic drugs market are the rise in the elderly population, the prevalence of eye diseases like glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in R&D activities by different healthcare companies. The major key players in this market are Pfizer Inc., Alcon, Novartis AG, Bausch Health Companies Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., Allergan (AbbVie Inc.), Bayer AG, Genentech, Inc. (F. Hoffmann-La Roche Ltd), Nicox, Coherus Biosciences, Inc.
Malaysia Opioid Drugs Market Analysis
Malaysia opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.
Malaysia Opioid Pain Management Market Analysis
Malaysia opioid pain management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopaedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., etc.
Malaysia Opioid Use Disorder Market Analysis
Malaysia opioid use disorder market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for opioid use disorders is anticipated to expand in the upcoming years as a result of factors such as an expansion of the patient base and the anticipated introduction of cutting-edge therapies by top firms like Braeburn Pharmaceuticals, BioXcel Therapeutics, MediciNova, AstraZeneca, and others. Some of the major key players in this market are AstraZeneca Plc., BioDelivery Sciences International Inc., Braeburn, Cerebral, Hikma Pharmaceuticals Plc., etc.
Malaysia Optogenetics Market Analysis
Malaysia optogenetics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of neurological illnesses, the rise in optogenetics R&D activities, and the rise in demand for neuroscience research are all contributing factors to the expansion of the optogenetics market. Some of the major key players in this market are Cobalt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, etc.